[Chevychelov]

Anticoagulation therapy: New score for hemorrhage risk

Gregory B. Lim
Abstract

A new scoring scheme to predict the risk of warfarin-associated hemorrhage in patients with atrial fibrillation (AF) has been published by researchers from the ATRIA (Anticoagulation and Risk Factors in AF) study group based at Kaiser Permanente in the US. Warfarin is commonly prescribed to patients with AF to reduce the risk of thrombosis, but according to Dr Margaret Fang, lead author of the report, “anticoagulants can significantly reduce a person's risk of AF-related stroke; however, anticoagulants also [confer] significant risks—in particular, an increased risk of bleeding.
[Ссылки доступны только зарегистрированным пользователям ]